Kronox Lab Sciences Q1 Results: Net profit up 60% YoY to ₹25.8 crore

1 min read     Updated on 16 Aug 2026, 01:12 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Kronox Lab Sciences posted strong Q1FY26 results with net profit jumping 60% YoY to ₹25.85 crore on the back of 34% revenue growth to ₹71.33 crore. Other income also increased significantly, supporting the overall profitability surge.

powered bylight_fuzz_icon
48411711

*this image is generated using AI for illustrative purposes only.

Kronox Lab Sciences Limited reported a significant improvement in profitability for the first quarter of FY26. The company’s net profit after tax rose 60% year-on-year to ₹25.85 crore, compared to ₹16.17 crore in the corresponding period of the previous fiscal. This growth was supported by a 34% increase in revenue from operations, which reached ₹71.33 crore against ₹53.32 crore in Q1FY25.

The company filed its unaudited financial results with stock exchanges on August 16, 2026, pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were published in Indian Express (English) and Financial Express (Gujarati) on August 14, 2026.

Financial Performance

Revenue from operations grew steadily, reflecting stronger business activity. Other income also saw a substantial increase, contributing to the bottom-line expansion. The total comprehensive income for the quarter stood at ₹25.85 crore.

Metric: Q1FY26 Q1FY25 Change
Revenue from operations: ₹71.33 crore ₹53.32 crore +34%
Net profit after tax: ₹25.85 crore ₹16.17 crore +60%
Total comprehensive income: ₹25.85 crore ₹16.17 crore +60%

What the Numbers Show

The divergence between revenue growth (34%) and profit growth (60%) indicates an expansion in operating leverage or a significant contribution from non-operating sources. With other income rising from ₹17.64 crore to ₹23.62 crore (+34%), it remains a material component of the company’s earnings structure, suggesting that profitability is partially dependent on factors beyond core operational revenue generation.

Regulatory Disclosures

Nikhil Goswami, Company Secretary and Compliance Officer (Membership No. A68272), signed off on the filing. The company also disclosed details regarding its registered office and corporate identification numbers as part of the standard regulatory requirements.

Historical Stock Returns for Kronox Lab Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
-2.97%-9.74%-0.11%+23.02%-6.33%-5.52%

How sustainable is the 60% profit growth given that other income constitutes a significant portion of total earnings compared to core operational revenue?

What specific strategic initiatives or market expansions are driving the 34% increase in revenue from operations for Kronox Lab Sciences?

Will the company's operating margins continue to expand in subsequent quarters, or is the current leverage a one-off result of favorable non-operating conditions?

Kronox Lab Sciences Q1 net profit up 16% YoY to ₹7.3 crore

2 min read     Updated on 12 Aug 2026, 11:33 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Kronox Lab Sciences posted a 16% YoY rise in Q1FY27 net profit to ₹7.3 crore, supported by 17% revenue growth to ₹2,838.6 lakh. Pre-tax margins expanded despite higher material costs. The board approved results and scheduled the AGM for September 16, 2026.

powered bylight_fuzz_icon
48096371

*this image is generated using AI for illustrative purposes only.

Kronox Lab Sciences reported a net profit of ₹730.3 lakh for the quarter ended June 30, 2026, an increase of 16% compared to ₹627.9 lakh in the same period of the previous fiscal year. Revenue from operations rose 17% year-on-year to ₹2,838.6 lakh, up from ₹2,428.7 lakh in Q1FY26.

The Vadodara-based specialty fine chemical manufacturer saw its profit before tax climb to ₹981.0 lakh from ₹844.1 lakh in the prior year quarter. This growth was underpinned by higher operational activity, reflected in increased cost of materials consumed, which rose to ₹1,509.3 lakh from ₹1,287.2 lakh year-on-year.

Financial Highlights

Metric: Q1FY27 (₹ in Lakhs) Q1FY26 (₹ in Lakhs) Change
Revenue from Operations: 2,838.6 2,428.7 +16.9%
Total Income: 2,968.3 2,516.0 +18.0%
Total Expenses: 1,987.3 1,671.9 +18.9%
Profit Before Tax: 981.0 844.1 +16.2%
Net Profit After Tax: 730.3 627.9 +16.3%
Earnings Per Share: ₹2.0 ₹1.7 +17.6%

Earnings per share stood at ₹2.0, compared to ₹1.7 in the corresponding quarter of FY26. Other income declined to ₹129.7 lakh from ₹214.6 lakh in the previous quarter but remained above the ₹87.3 lakh recorded in Q1FY26.

What the Numbers Show

The company’s top-line growth outpaced the rise in total expenses, resulting in an expansion of pre-tax margins. While revenue grew nearly 17%, total expenses increased by approximately 19%, primarily driven by a rise in cost of materials consumed and other expenses, which jumped to ₹347.6 lakh from ₹277.9 lakh year-on-year. Despite this pressure on costs, net profit maintained a robust growth trajectory, indicating effective management of operational leverage amidst higher input costs.

Corporate Actions

The Board of Directors, in its meeting held on August 12, 2026, approved the unaudited standalone financial results for the quarter ended June 30, 2026. The results were reviewed by statutory auditors Mahesh Udhwani & Associates.

Key decisions included:

  • Convening the 17th Annual General Meeting (AGM) on September 16, 2026.
  • Closure of the Register of Members and Share Transfer Books from September 10, 2026, to September 16, 2026, to determine eligibility for the final dividend, if declared.
  • Re-appointment of M/s. Jaimin & Associates as Internal Auditors for the financial year 2026-27.
  • Appointment of M/s. Diwanji & Associates as Cost Auditors for the financial year 2026-27.

Historical Stock Returns for Kronox Lab Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
-2.97%-9.74%-0.11%+23.02%-6.33%-5.52%

Will the decline in other income continue to pressure overall profitability in upcoming quarters despite strong operational revenue growth?

How sustainable is the current margin expansion given the 19% rise in total expenses outpacing the 17% revenue growth?

What specific strategies is Kronox Lab Sciences employing to mitigate the rising cost of materials consumed in the fine chemical sector?

More News on Kronox Lab Sciences

1 Year Returns:-6.33%